Clobetasone Butyrate

CAS 25122-57-0 2 current recordsSmall Molecule

Who holds supplier records for Clobetasone Butyrate? 2 organisations hold a current record for Clobetasone Butyrate: an active US FDA Type II Drug Master File or a CEP. 2 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (2).

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Clobetasone Butyrate: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/clobetasone-butyrate

Reading the evidence

  • 2 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • Most recorded organisations are in India

    2 of the 2 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.

  • 1 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (2)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Clobetasone Butyrate. Country is the organisation's recorded country, not necessarily the manufacturing site.

  • IndiaCEP Company GMP cert on record
  • AVIK PHARMACEUTICAL LIMITED
    Valid CEP holder (EDQM); not necessarily the manufacturer
    IndiaCEP
Need Clobetasone Butyrate sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Valid CEP holder entries (2)

Certificates of Suitability on the EDQM register for Clobetasone Butyrate, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 4 certificates in total, including withdrawn, expired, suspended and repeat certificates.

HolderCountryCertificateIssuedEU GMP at holder's address
SYMBIOTEC PHARMALAB LIMITED IndoreIN
CEP 2012-282 - Rev 02
Clobetasone butyrate, Micronised
Apr 2026Inspected Mar 2026
Germany
AVIK PHARMACEUTICAL LIMITED VapiIN
CEP 2018-105 - Rev 01
Clobetasone butyrate
Oct 2024—

The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.

Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.

Overview

Clobetasone Butyrate is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL2308885).

Chemical identity

IUPAC name
[(8S,9S,10S,13S,14R,16R,17R)-17-(2-chloroacetyl)-9-fluoro-10,13,16-trimethyl-3,11-dioxo-7,8,12,14,15,16-hexahydro-6H-cyclopenta[a]phenanthren-17-yl] butanoate
Canonical SMILES
CCCC(=O)O[C@@]1([C@@H](C[C@H]2[C@@]1(CC(=O)[C@@]3([C@H]2CCC4=CC(=O)C=C[C@@]43C)F)C)C)C(=O)CCl
InChIKey
FBRAWBYQGRLCEK-RJFLZJKCSA-N
Synonyms
CCI 5537, CCI-5537, Clobavate, Clobet, Clobetasone 17-butyrate, Clobetasone butyrate, Cloburate, Cloburate-n, Eumovate, Eumovate n, GR 2/1214, GR-2/1214

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Clobetasone Butyrate?

2 organisations hold an active US FDA Type II Drug Master File or a CEP for Clobetasone Butyrate: SYMBIOTEC PHARMALAB PRIVATE LTD (India) and AVIK PHARMACEUTICAL LIMITED (India). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Does Clobetasone Butyrate have a European Certificate of Suitability?

Yes. 2 organisations hold a valid CEP for Clobetasone Butyrate on the EDQM register, including SYMBIOTEC PHARMALAB LIMITED Indore (IN) and AVIK PHARMACEUTICAL LIMITED Vapi (IN). A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

How do I qualify a Clobetasone Butyrate supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Clobetasone Butyrate?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.